Eswatini
5 Vaccines Approved for Use in Eswatini
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: eswatinihealth.org
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: aa.com.tr
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: afro.who.int
Protein Subunit
Medigen
MVC-COV1901
Approved in 4 countries
15 trials in 4 countries
Approval Source: metrotvnews.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: aa.com.tr
1 in Clinical Trials in Eswatini
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries